凝固市場規模・予測(2020年~2030年)、世界・地域シェア、動向、成長機会分析レポート収録範囲適応疾患別(ビタミンK欠乏症、肝疾患、播種性血管内凝固・肺塞栓症、循環性抗凝固薬の開発、血友病、フォンウィルブランド病、その他)、タイプ別(臨床検査分析装置(コントロール&キャリブレーター、臨床検査分析装置(コントロール&キャリブレーター、アッセイ&試薬、装置/システム、凝固因子、その他)およびPOC検査分析装置]、提供サービス[診断(プロトロンビン時間検査、フィブリノーゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査、D-ダイマー検査、血小板機能検査、その他)、治療(抗線溶薬、避妊薬、デスモプレシンおよび免疫抑制薬、ビタミンKサプリメント、血液凝固阻止薬、トロンビン阻害薬または血栓溶解薬、補充療法、カテーテルによる血栓除去、その他)]、技術(光学技術、機械技術、電気化学技術、その他)、エンドユーザー(臨床検査室、病院、その他)、地域(北米、欧州、アジア太平洋、中南米、中東アフリカ)Coagulation Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand's Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa) 凝固市場は、2022年の62億9,500万米ドルから2030年には108億5,300万米ドルに成長すると予想され、2022年から2030年までの年平均成長率は7.0%を記録すると予測されている。 生活習慣の変化と老年人口の増加は... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー凝固市場は、2022年の62億9,500万米ドルから2030年には108億5,300万米ドルに成長すると予想され、2022年から2030年までの年平均成長率は7.0%を記録すると予測されている。生活習慣の変化と老年人口の増加は、血液疾患の有病率を高める主な要因のひとつである。そのため、早期診断と早期治療に対する需要が高まっている。主要企業は、患者集団の生活の質を高めるために、有機的・無機的なさまざまな戦略を通じて、いくつかの取り組みを行っている。 - 2020年7月、シスメックス株式会社は自動血液凝固分析装置CN-6500/CN-3500を日本で発売した。この分析装置は、血液凝固・血小板凝集パラメータ、血栓症・止血パラメータを測定する。 - 2020年4月、米国のHaemonetics Corporationは血液凝固診断システム開発会社のEnicorを買収した。 - 2021年10月、Trivitron HealthcareはインドのDiagon Ltdが製造する新しい凝固分析装置製品ラインを発売した。 - 2021年6月、トリビトロン・ヘルスケアは糖尿病、ヘモグロビン変動、サラセミアのモニタリングに役立つNANO H5とNANO H110を発表。 - 2021年2月、シーメンス・ヘルティニアーズとシスメックス・コーポレーションは、全世界における止血製品の供給、流通、販売、サービスに関する契約を更新した。この契約には複数年の延長も含まれている。さらに、シーメンス・ヘルスイニアーズ社は、シスメックス社のCN-3000やCN-6000などの自動血液凝固分析装置の販売にも合意した。 - 2022年7月、堀場メディカルは最新の止血分析装置「Yumizen G800」と「G1550」、および一般的な血液凝固検査に便利な即使用可能な試薬を発売した。この製品ラインナップの拡充により、HORIBA Medicalは、あらゆる規模や要件の検査室向けに、包括的な止血システムと高度な試薬のセレクションを提供することになった。 このように、主要市場プレーヤーによる有機的・無機的なさまざまな戦略の採用は、予測期間中、凝固市場成長の機会を提供すると期待される。 心血管疾患の有病率の上昇が凝固市場の成長を牽引 心疾患は、心房細動や脳卒中などの状態による入院、死亡、身体能力の低下の主な原因の1つである。心臓病は止血系、血管系、血液の流体力学に影響を及ぼし、動脈血栓症や静脈血栓症を引き起こす。血栓症は心血管系疾患による死亡および合併症の主な原因である。喫煙や高血圧によって損傷を受けた血管は、血管を覆うコレステロールを多く含むプラークを形成し、これが破裂して血小板が凝固することがある。凝固障害では、心筋梗塞、脳卒中、血管床でのアテローム血栓性イベントのリスクがある。心不全(HF)は心房細動(AF)の有無とは無関係に血栓塞栓症のリスク上昇に関係する。血小板の活性化や凝固系の異常は,心不全患者における重篤な血栓塞栓症のリスクを増大させる。 2022 Heart Disease & Stroke Statistical Update Fact Sheetによると、2020年には世界中でCVDによる死亡が1億1,910万人、脳卒中と虚血性脳卒中の症例がそれぞれ8,910万人と6,820万人記録されている。National Center for Chronic Disease Prevention and Health Promotionによると、2023年、米国では毎年877,500人が心臓病で死亡すると報告されている。米国心臓協会によると、2035年までに1億3,000万人以上のアメリカ人が何らかの形でCVDを発症する可能性がある。Global Burden of Disease Study 2019』によると、2019年のアジア太平洋地域の死因のトップはCVDで、1,080万人(死亡者全体の35%)を引き起こしている。 凝固検査は、心臓発作を引き起こす可能性のある血液凝固を予防するのに役立つ。凝固分析装置は、冠動脈バイパス手術や血管形成術の際に使用され、血液凝固状態に関する情報を監視する。このように、心血管疾患の罹患率の増加が凝固市場の成長を後押ししている。 凝固市場は、適応疾患、タイプ、提供、技術、エンドユーザー、地域によって区分される。適応疾患別では、凝固市場はビタミンK欠乏症、肝疾患、播種性血管内凝固・肺塞栓症、循環性抗凝固薬開発、血友病、von Willebrand病、その他に区分される。凝固市場はタイプ別に、臨床検査用分析装置とポイントオブケア検査用分析装置に区分される。臨床検査分析装置は、コントロール&キャリブレーター、アッセイ&試薬、機器/システム、凝固因子、その他で構成される。凝固市場は提供する製品によって診断と治療に区分される。診断セグメントはさらに、プロトロンビン時間検査、フィブリノゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査、Dダイマー検査、血小板機能検査、その他に分類される。治療分野はさらに、抗線溶薬、避妊薬、デスモプレシン&免疫抑制薬、ビタミンKサプリメント、血液希釈薬、トロンビン阻害薬または血栓溶解薬、補充療法、カテーテル補助血栓除去、その他に分類される。技術別では、凝固市場は光学技術、機械技術、電気化学技術、その他に区分される。エンドユーザーに基づくと、凝固市場は臨床検査室、病院、その他に区分される。 地域別では、北米、欧州、アジア太平洋、中東・アフリカ、中南米に区分される。凝固市場で最大のシェアを占めるのは北米である。北米が大きな市場シェアを占めているのは、血液疾患の増加、心房細動(AFib)などの心血管系疾患の増加、新規および既存の製品開発に従事する大手市場プレイヤーの存在によるものである。北米の凝固市場は米国が最大のシェアを占めている。血液疾患患者の急増、心血管疾患の有病率の増加、血液疾患予防のための政府支援などが、予測期間中の北米凝固市場の成長を後押しすると予想される。カナダ予防医療タスクフォース(Canadian Task Force on Preventive Health Care)によると、カナダにおける心房細動の発症率は年間4.5%増加し、40歳以上の生涯リスクは25%に達する。約30万人のカナダ人が遺伝性の出血性疾患遺伝子を持っている。このうち10人に1人、少なくとも3万人のカナダ人が、医療を必要とするほど重篤な症状を持っている。その多くは適切な診断を受けていない。遺伝性出血性疾患のための包括的ケアクリニックのカナダのネットワークに登録されている遺伝性出血性疾患の患者はわずか10,000人である。カナダ血友病協会によると、〜30万人のカナダ人が遺伝性血液疾患の遺伝子を持っている。したがって、先天性血液疾患の症例数の増加は、カナダにおける凝固市場の成長と関連づけることができる。 米国心臓協会(AHA)、米国疾病予防管理センター(CDC)、欧州連合(EU)、カナダ予防医療タスクフォース(Canadian Task Force on Preventive Health Care)などは、凝固市場に関する報告書を作成する際に参照した主要な一次情報源および二次情報源である。 目次TABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Coagulation Market Landscape 4.1 Overview 4.2 PEST Analysis 5. Coagulation Market - Key Industry Dynamics 5.1 Key Market Drivers: 5.1.1 Market Drivers 5.1.2 Increasing Prevalence of Blood Disorders 5.1.3 Rising Prevalence of Cardiovascular Diseases 5.2 Market Restraints 5.2.1 High Costs Associated with Coagulation Analyzers 5.3 Market Opportunities 5.3.1 Growing Organic and Inorganic Strategies by Key Market Players 5.4 Future Trends 5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers 5.5 Impact Analysis 6. Coagulation Market - Global Market Analysis 6.1 Coagulation Market Revenue (US$ million), 2022 – 2030 6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030 7. Global Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication 7.1 Overview 7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%) 7.3 Vitamin K Deficiency 7.3.1 Overview 7.3.2 Vitamin K Deficiency: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.4 Liver Disease 7.4.1 Overview 7.4.2 Liver Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism 7.5.1 Overview 7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.6 Development of Circulating Anticoagulant 7.6.1 Overview 7.6.2 Development of Circulating Anticoagulant: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.7 Hemophilia 7.7.1 Overview 7.7.2 Hemophilia: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.8 Von Willebrand's Disease 7.8.1 Overview 7.8.2 Von Willebrand's Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.9 Others 7.9.1 Overview 7.9.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 8. Global Coagulation Market – Revenue and Forecast to 2030 – by Type 8.1 Overview 8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%) 8.3 Clinical Laboratory Analyzers 8.3.1 Overview 8.3.2 Clinical Laboratory Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers 8.4 Point-of-Care Testing Analyzers 8.4.1 Overview 8.4.2 Point-of-Care Testing Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 9. Global Coagulation Market – Revenue and Forecast to 2030 – by Offering 9.1 Overview 9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%) 9.3 Diagnosis 9.3.1 Overview 9.3.2 Diagnosis: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 9.3.2.1 Global Coagulation Market, by Diagnosis 9.4 Treatment 9.4.1 Overview 9.4.2 Treatment: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 9.4.2.1 Global Coagulation Market, by Treatment 10. Global Coagulation Market – Revenue and Forecast to 2030 – by Technology 10.1 Overview 10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%) 10.3 Optical Technology 10.3.1 Overview 10.3.2 Optical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 10.4 Mechanical Technology 10.4.1 Overview 10.4.2 Mechanical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 10.5 Electrochemical Technology 10.5.1 Overview 10.5.2 Electrochemical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 10.6 Others 10.6.1 Overview 10.6.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 11. Global Coagulation Market – Revenue and Forecast to 2030 – by End User 11.1 Overview 11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%) 11.3 Clinical Laboratories 11.3.1 Overview 11.3.2 Clinical Laboratories: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 11.4 Hospitals 11.4.1 Overview 11.4.2 Hospitals: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 11.5 Others 11.5.1 Overview 11.5.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 12. Coagulation Market - Geographical Analysis 12.1 North America Coagulation Market, Revenue And Forecast To 2030 12.1.1 Overview 12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.3 North America Coagulation Market, by Disease Indication 12.1.4 North America Coagulation Market, by Type 12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers 12.1.5 North America Coagulation Market, by Offering 12.1.5.1 North America Coagulation Market, by Diagnosis 12.1.5.2 North America Coagulation Market, by Treatment 12.1.6 North America Coagulation Market, by Technology 12.1.7 North America Coagulation Market, by End User 12.1.7.1 North America Coagulation Market, by Country 12.1.7.2 US 12.1.7.2.1 Overview 12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.7.2.3 US Coagulation Market, by Disease Indication 12.1.7.2.4 US Coagulation Market, by Type 12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers 12.1.7.2.5 US Coagulation Market, by Offering 12.1.7.2.5.1 US Coagulation Market, by Diagnosis 12.1.7.2.5.2 US Coagulation Market, by Treatment 12.1.7.2.6 US Coagulation Market, by Technology 12.1.7.2.7 US Coagulation Market, by End User 12.1.7.3 Canada 12.1.7.3.1 Overview 12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.7.3.3 Canada Coagulation Market, by Disease Indication 12.1.7.3.4 Canada Coagulation Market, by Type 12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers 12.1.7.3.5 Canada Coagulation Market, by Offering 12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis 12.1.7.3.5.2 Canada Coagulation Market, by Treatment 12.1.7.3.6 Canada Coagulation Market, by Technology 12.1.7.3.7 Canada Coagulation Market, by End User 12.1.7.4 Mexico 12.1.7.4.1 Overview 12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.7.4.3 Mexico Coagulation Market, by Disease Indication 12.1.7.4.4 Mexico Coagulation Market, by Type 12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers 12.1.7.4.5 Mexico Coagulation Market, by Offering 12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis 12.1.7.4.5.2 US Coagulation Market, by Treatment 12.1.7.4.6 Mexico Coagulation Market, by Technology 12.1.7.4.7 Mexico Coagulation Market, by End User 12.2 Europe Coagulation Market, Revenue And Forecast to 2030 12.2.1 Overview 12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.3 Europe Coagulation Market, by Disease Indication 12.2.4 Europe Coagulation Market, by Type 12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers 12.2.5 Europe Coagulation Market, by Offering 12.2.5.1 Europe Coagulation Market, by Diagnosis 12.2.5.2 Europe Coagulation Market, by Treatment 12.2.6 Europe Coagulation Market, by Technology 12.2.7 Europe Coagulation Market, by End User 12.2.8 Europe Coagulation Market by Country 12.2.8.1 Germany 12.2.8.1.1 Overview 12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.1.3 Germany Coagulation Market, by Disease Indication 12.2.8.1.4 Germany Coagulation Market, by Type 12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.1.5 Germany Coagulation Market, by Offering 12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis 12.2.8.1.5.2 Germany Coagulation Market, by Treatment 12.2.8.1.6 Germany Coagulation Market, by Technology 12.2.8.1.7 Germany Coagulation Market, by End User 12.2.8.2 UK 12.2.8.2.1 Overview 12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.2.2 UK Coagulation Market, by Disease Indication 12.2.8.2.3 UK Coagulation Market, by Type 12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.2.4 UK Coagulation Market, by Offering 12.2.8.2.4.1 UK Coagulation Market, by Diagnosis 12.2.8.2.4.2 UK Coagulation Market, by Treatment 12.2.8.2.5 UK Coagulation Market, by Technology 12.2.8.2.6 UK Coagulation Market, by End User 12.2.8.3 France 12.2.8.3.1 Overview 12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.3.2 France Coagulation Market, by Disease Indication 12.2.8.3.3 France Coagulation Market, by Type 12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.3.4 France Coagulation Market, by Offering 12.2.8.3.4.1 France Coagulation Market, by Diagnosis 12.2.8.3.4.2 France Coagulation Market, by Treatment 12.2.8.3.5 France Coagulation Market, by Technology 12.2.8.3.6 France Coagulation Market, by End User 12.2.8.4 Italy 12.2.8.4.1 Overview 12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.4.2 Italy Coagulation Market, by Disease Indication 12.2.8.4.3 Italy Coagulation Market, by Type 12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.4.4 Italy Coagulation Market, by Offering 12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis 12.2.8.4.4.2 Italy Coagulation Market, by Treatment 12.2.8.4.5 Italy Coagulation Market, by Technology 12.2.8.4.6 Italy Coagulation Market, by End User 12.2.8.5 Spain 12.2.8.5.1 Overview 12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.5.3 Spain Coagulation Market, by Disease Indication 12.2.8.5.4 Spain Coagulation Market, by Type 12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.5.5 Spain Coagulation Market, by Offering 12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis 12.2.8.5.5.2 Spain Coagulation Market, by Treatment 12.2.8.5.6 Spain Coagulation Market, by Technology 12.2.8.5.7 Spain Coagulation Market, by End User 12.2.8.6 Rest of Europe 12.2.8.6.1 Overview 12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication 12.2.8.6.4 Rest of Europe Coagulation Market, by Type 12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.6.5 Rest of Europe Coagulation Market, by Offering 12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis 12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment 12.2.8.6.6 Rest of Europe Coagulation Market, by Technology 12.2.8.6.7 Rest of Europe Coagulation Market, by End User 12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030 12.3.1 Overview 12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.3 Asia Pacific Coagulation Market, by Disease Indication 12.3.4 Asia Pacific Coagulation Market, by Type 12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer 12.3.5 Asia Pacific Coagulation Market, by Offering 12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis 12.3.5.2 Asia Pacific Coagulation Market, by Treatment 12.3.6 Asia Pacific Coagulation Market, by Technology 12.3.7 Asia Pacific Coagulation Market, by End User 12.3.8 Asia Pacific Coagulation Market by Country 12.3.8.1 China 12.3.8.1.1 Overview 12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.1.3 China Coagulation Market, by Disease Indication 12.3.8.1.4 China Coagulation Market, by Type 12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.1.5 China Coagulation Market, by Offering 12.3.8.1.5.1 China Coagulation Market, by Diagnosis 12.3.8.1.5.2 China Coagulation Market, by Treatment 12.3.8.1.6 China Coagulation Market, by Technology 12.3.8.1.7 China Coagulation Market, by End User 12.3.8.2 Japan 12.3.8.2.1 Overview 12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.2.3 Japan Coagulation Market, by Disease Indication 12.3.8.2.4 Japan Coagulation Market, by Type 12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.2.5 Japan Coagulation Market, by Offering 12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis 12.3.8.2.5.2 Japan Coagulation Market, by Treatment 12.3.8.2.6 Japan Coagulation Market, by Technology 12.3.8.2.7 Japan Coagulation Market, by End User 12.3.8.3 India 12.3.8.3.1 Overview 12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.3.3 India Coagulation Market, by Disease Indication 12.3.8.3.4 India Coagulation Market, by Type 12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.3.5 India Coagulation Market, by Offering 12.3.8.3.5.1 India Coagulation Market, by Diagnosis 12.3.8.3.5.2 India Coagulation Market, by Treatment 12.3.8.3.6 India Coagulation Market, by Technology 12.3.8.3.7 India Coagulation Market, by End User 12.3.8.4 Australia 12.3.8.4.1 Overview 12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.4.3 Australia Coagulation Market, by Disease Indication 12.3.8.4.4 Australia Coagulation Market, by Type 12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.4.5 Australia Coagulation Market, by Offering 12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis 12.3.8.4.5.2 Australia Coagulation Market, by Treatment 12.3.8.4.6 Australia Coagulation Market, by Technology 12.3.8.4.7 Australia Coagulation Market, by End User 12.3.8.5 South Korea 12.3.8.5.1 Overview 12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.5.3 South Korea Coagulation Market, by Disease Indication 12.3.8.5.4 South Korea Coagulation Market, by Type 12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.5.5 South Korea Coagulation Market, by Offering 12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis 12.3.8.5.5.2 South Korea Coagulation Market, by Treatment 12.3.8.5.6 South Korea Coagulation Market, by Technology 12.3.8.5.7 South Korea Coagulation Market, by End User 12.3.8.6 Rest of Asia Pacific 12.3.8.6.1 Overview 12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication 12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type 12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering 12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis 12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment 12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology 12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User 12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030 12.4.1 Overview 12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.3 Middle East & Africa Coagulation Market, by Disease Indication 12.4.4 Middle East & Africa Coagulation Market, by Type 12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer 12.4.5 Middle East & Africa Coagulation Market, by Offering 12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis 12.4.5.2 Middle East & Africa Coagulation Market, by Treatment 12.4.6 Middle East & Africa Coagulation Market, by Technology 12.4.7 Middle East & Africa Coagulation Market, by End User 12.4.7.1 Middle East & Africa Coagulation Market by Country 12.4.7.2 Saudi Arabia 12.4.7.2.1 Overview 12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication 12.4.7.2.4 Saudi Arabia Coagulation Market, by Type 12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering 12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis 12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment 12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology 12.4.7.2.7 Saudi Arabia Coagulation Market, by End User 12.4.7.3 South Africa 12.4.7.3.1 Overview 12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.3.3 South Africa Coagulation Market, by Disease Indication 12.4.7.3.4 South Africa Coagulation Market, by Type 12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.3.5 South Africa Coagulation Market, by Offering 12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis 12.4.7.3.5.2 South Africa Coagulation Market, by Treatment 12.4.7.3.6 South Africa Coagulation Market, by Technology 12.4.7.3.7 South Africa Coagulation Market, by End User 12.4.7.4 UAE 12.4.7.4.1 Overview 12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.4.3 UAE Coagulation Market, by Disease Indication 12.4.7.4.4 UAE Coagulation Market, by Type 12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.4.5 UAE Coagulation Market, by Offering 12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis 12.4.7.4.5.2 UAE Coagulation Market, by Treatment 12.4.7.4.6 UAE Coagulation Market, by Technology 12.4.7.4.7 UAE Coagulation Market, by End User 12.4.7.5 Rest of Middle East & Africa 12.4.7.5.1 Overview 12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication 12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type 12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering 12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis 12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment 12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology 12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User 12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030 12.5.1 Overview 12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.3 South & Central America Coagulation Market, by Disease Indication 12.5.4 South & Central America Coagulation Market, by Type 12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer 12.5.5 South & Central America Coagulation Market, by Offering 12.5.5.1 South & Central America Coagulation Market, by Diagnosis 12.5.5.2 South & Central America Coagulation Market, by Treatment 12.5.6 South & Central America Coagulation Market, by Technology 12.5.7 South & Central America Coagulation Market, by End User 12.5.8 South & Central America Coagulation Market by Country 12.5.8.1 Brazil 12.5.8.1.1 Overview 12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.8.1.3 Brazil Coagulation Market, by Disease Indication 12.5.8.1.4 Brazil Coagulation Market, by Type 12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer 12.5.8.1.5 Brazil Coagulation Market, by Offering 12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis 12.5.8.1.5.2 Brazil Coagulation Market, by Treatment 12.5.8.1.6 Brazil Coagulation Market, by Technology 12.5.8.1.7 Brazil Coagulation Market, by End User 12.5.8.2 Argentina 12.5.8.2.1 Overview 12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.8.2.3 Argentina Coagulation Market, by Disease Indication 12.5.8.2.4 Argentina Coagulation Market, by Type 12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer 12.5.8.2.5 Argentina Coagulation Market, by Offering 12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis 12.5.8.2.5.2 Argentina Coagulation Market, by Treatment 12.5.8.2.6 Argentina Coagulation Market, by Technology 12.5.8.2.7 Argentina Coagulation Market, by End User 12.5.8.3 Rest of South & Central America 12.5.8.3.1 Overview 12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication 12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type 12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer 12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering 12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis 12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment 12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology 12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User 13. Coagulation Market–Industry Landscape 13.1 Overview 13.2 Growth Strategies in the Coagulation Market 13.3 Inorganic Growth Strategies 13.3.1 Overview 13.4 Organic Growth Strategies 13.4.1 Overview 14. Company Profiles 14.1 Siemens Healthineers AG 14.1.1 Key Facts 14.1.2 Business Description 14.1.3 Products and Services 14.1.4 Financial Overview 14.1.5 SWOT Analysis 14.1.6 Key Developments 14.2 Diagnostica Stago, Inc 14.2.1 Key Facts 14.2.2 Business Description 14.2.3 Products and Services 14.2.4 Financial Overview 14.2.5 SWOT Analysis 14.2.6 Key Developments 14.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti. 14.3.1 Key Facts 14.3.2 Business Description 14.3.3 Products and Services 14.3.4 Financial Overview 14.3.5 SWOT Analysis 14.3.6 Key Developments 14.4 Nordic Biomarker AB 14.4.1 Key Facts 14.4.2 Business Description 14.4.3 Products and Services 14.4.4 Financial Overview 14.4.5 SWOT Analysis 14.4.6 Key Developments 14.5 Sysmex Corp 14.5.1 Key Facts 14.5.2 Business Description 14.5.3 Products and Services 14.5.4 Financial Overview 14.5.5 SWOT Analysis 14.5.6 Key Developments 14.6 Helena Laboratories Corporation 14.6.1 Key Facts 14.6.2 Business Description 14.6.3 Products and Services 14.6.4 Financial Overview 14.6.5 SWOT Analysis 14.6.6 Key Developments 14.7 F. Hoffmann-La Roche Ltd 14.7.1 Key Facts 14.7.2 Business Description 14.7.3 Products and Services 14.7.4 Financial Overview 14.7.5 SWOT Analysis 14.7.6 Key Developments 14.8 Genrui Biotech Co., Ltd. 14.8.1 Key Facts 14.8.2 Business Description 14.8.3 Products and Services 14.8.4 Financial Overview 14.8.5 SWOT Analysis 14.8.6 Key Developments 14.9 Transasia Bio-Medicals Ltd 14.9.1 Key Facts 14.9.2 Business Description 14.9.3 Products and Services 14.9.4 Financial Overview 14.9.5 SWOT Analysis 14.9.6 Key Developments 14.10 Horiba Ltd. 14.10.1 Key Facts 14.10.2 Business Description 14.10.3 Products and Services 14.10.4 Financial Overview 14.10.5 SWOT Analysis 14.10.6 Key Developments 15. Appendix 15.1 About Us 15.2 Glossary of Terms
SummaryThe coagulation market is expected to grow from US$ 6.295 billion in 2022 to US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Coagulation Market Landscape 4.1 Overview 4.2 PEST Analysis 5. Coagulation Market - Key Industry Dynamics 5.1 Key Market Drivers: 5.1.1 Market Drivers 5.1.2 Increasing Prevalence of Blood Disorders 5.1.3 Rising Prevalence of Cardiovascular Diseases 5.2 Market Restraints 5.2.1 High Costs Associated with Coagulation Analyzers 5.3 Market Opportunities 5.3.1 Growing Organic and Inorganic Strategies by Key Market Players 5.4 Future Trends 5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers 5.5 Impact Analysis 6. Coagulation Market - Global Market Analysis 6.1 Coagulation Market Revenue (US$ million), 2022 – 2030 6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030 7. Global Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication 7.1 Overview 7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%) 7.3 Vitamin K Deficiency 7.3.1 Overview 7.3.2 Vitamin K Deficiency: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.4 Liver Disease 7.4.1 Overview 7.4.2 Liver Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism 7.5.1 Overview 7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.6 Development of Circulating Anticoagulant 7.6.1 Overview 7.6.2 Development of Circulating Anticoagulant: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.7 Hemophilia 7.7.1 Overview 7.7.2 Hemophilia: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.8 Von Willebrand's Disease 7.8.1 Overview 7.8.2 Von Willebrand's Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 7.9 Others 7.9.1 Overview 7.9.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 8. Global Coagulation Market – Revenue and Forecast to 2030 – by Type 8.1 Overview 8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%) 8.3 Clinical Laboratory Analyzers 8.3.1 Overview 8.3.2 Clinical Laboratory Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers 8.4 Point-of-Care Testing Analyzers 8.4.1 Overview 8.4.2 Point-of-Care Testing Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 9. Global Coagulation Market – Revenue and Forecast to 2030 – by Offering 9.1 Overview 9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%) 9.3 Diagnosis 9.3.1 Overview 9.3.2 Diagnosis: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 9.3.2.1 Global Coagulation Market, by Diagnosis 9.4 Treatment 9.4.1 Overview 9.4.2 Treatment: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 9.4.2.1 Global Coagulation Market, by Treatment 10. Global Coagulation Market – Revenue and Forecast to 2030 – by Technology 10.1 Overview 10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%) 10.3 Optical Technology 10.3.1 Overview 10.3.2 Optical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 10.4 Mechanical Technology 10.4.1 Overview 10.4.2 Mechanical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 10.5 Electrochemical Technology 10.5.1 Overview 10.5.2 Electrochemical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 10.6 Others 10.6.1 Overview 10.6.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 11. Global Coagulation Market – Revenue and Forecast to 2030 – by End User 11.1 Overview 11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%) 11.3 Clinical Laboratories 11.3.1 Overview 11.3.2 Clinical Laboratories: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 11.4 Hospitals 11.4.1 Overview 11.4.2 Hospitals: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 11.5 Others 11.5.1 Overview 11.5.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million) 12. Coagulation Market - Geographical Analysis 12.1 North America Coagulation Market, Revenue And Forecast To 2030 12.1.1 Overview 12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.3 North America Coagulation Market, by Disease Indication 12.1.4 North America Coagulation Market, by Type 12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers 12.1.5 North America Coagulation Market, by Offering 12.1.5.1 North America Coagulation Market, by Diagnosis 12.1.5.2 North America Coagulation Market, by Treatment 12.1.6 North America Coagulation Market, by Technology 12.1.7 North America Coagulation Market, by End User 12.1.7.1 North America Coagulation Market, by Country 12.1.7.2 US 12.1.7.2.1 Overview 12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.7.2.3 US Coagulation Market, by Disease Indication 12.1.7.2.4 US Coagulation Market, by Type 12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers 12.1.7.2.5 US Coagulation Market, by Offering 12.1.7.2.5.1 US Coagulation Market, by Diagnosis 12.1.7.2.5.2 US Coagulation Market, by Treatment 12.1.7.2.6 US Coagulation Market, by Technology 12.1.7.2.7 US Coagulation Market, by End User 12.1.7.3 Canada 12.1.7.3.1 Overview 12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.7.3.3 Canada Coagulation Market, by Disease Indication 12.1.7.3.4 Canada Coagulation Market, by Type 12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers 12.1.7.3.5 Canada Coagulation Market, by Offering 12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis 12.1.7.3.5.2 Canada Coagulation Market, by Treatment 12.1.7.3.6 Canada Coagulation Market, by Technology 12.1.7.3.7 Canada Coagulation Market, by End User 12.1.7.4 Mexico 12.1.7.4.1 Overview 12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.1.7.4.3 Mexico Coagulation Market, by Disease Indication 12.1.7.4.4 Mexico Coagulation Market, by Type 12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers 12.1.7.4.5 Mexico Coagulation Market, by Offering 12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis 12.1.7.4.5.2 US Coagulation Market, by Treatment 12.1.7.4.6 Mexico Coagulation Market, by Technology 12.1.7.4.7 Mexico Coagulation Market, by End User 12.2 Europe Coagulation Market, Revenue And Forecast to 2030 12.2.1 Overview 12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.3 Europe Coagulation Market, by Disease Indication 12.2.4 Europe Coagulation Market, by Type 12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers 12.2.5 Europe Coagulation Market, by Offering 12.2.5.1 Europe Coagulation Market, by Diagnosis 12.2.5.2 Europe Coagulation Market, by Treatment 12.2.6 Europe Coagulation Market, by Technology 12.2.7 Europe Coagulation Market, by End User 12.2.8 Europe Coagulation Market by Country 12.2.8.1 Germany 12.2.8.1.1 Overview 12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.1.3 Germany Coagulation Market, by Disease Indication 12.2.8.1.4 Germany Coagulation Market, by Type 12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.1.5 Germany Coagulation Market, by Offering 12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis 12.2.8.1.5.2 Germany Coagulation Market, by Treatment 12.2.8.1.6 Germany Coagulation Market, by Technology 12.2.8.1.7 Germany Coagulation Market, by End User 12.2.8.2 UK 12.2.8.2.1 Overview 12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.2.2 UK Coagulation Market, by Disease Indication 12.2.8.2.3 UK Coagulation Market, by Type 12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.2.4 UK Coagulation Market, by Offering 12.2.8.2.4.1 UK Coagulation Market, by Diagnosis 12.2.8.2.4.2 UK Coagulation Market, by Treatment 12.2.8.2.5 UK Coagulation Market, by Technology 12.2.8.2.6 UK Coagulation Market, by End User 12.2.8.3 France 12.2.8.3.1 Overview 12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.3.2 France Coagulation Market, by Disease Indication 12.2.8.3.3 France Coagulation Market, by Type 12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.3.4 France Coagulation Market, by Offering 12.2.8.3.4.1 France Coagulation Market, by Diagnosis 12.2.8.3.4.2 France Coagulation Market, by Treatment 12.2.8.3.5 France Coagulation Market, by Technology 12.2.8.3.6 France Coagulation Market, by End User 12.2.8.4 Italy 12.2.8.4.1 Overview 12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.4.2 Italy Coagulation Market, by Disease Indication 12.2.8.4.3 Italy Coagulation Market, by Type 12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.4.4 Italy Coagulation Market, by Offering 12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis 12.2.8.4.4.2 Italy Coagulation Market, by Treatment 12.2.8.4.5 Italy Coagulation Market, by Technology 12.2.8.4.6 Italy Coagulation Market, by End User 12.2.8.5 Spain 12.2.8.5.1 Overview 12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.5.3 Spain Coagulation Market, by Disease Indication 12.2.8.5.4 Spain Coagulation Market, by Type 12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.5.5 Spain Coagulation Market, by Offering 12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis 12.2.8.5.5.2 Spain Coagulation Market, by Treatment 12.2.8.5.6 Spain Coagulation Market, by Technology 12.2.8.5.7 Spain Coagulation Market, by End User 12.2.8.6 Rest of Europe 12.2.8.6.1 Overview 12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication 12.2.8.6.4 Rest of Europe Coagulation Market, by Type 12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers 12.2.8.6.5 Rest of Europe Coagulation Market, by Offering 12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis 12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment 12.2.8.6.6 Rest of Europe Coagulation Market, by Technology 12.2.8.6.7 Rest of Europe Coagulation Market, by End User 12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030 12.3.1 Overview 12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.3 Asia Pacific Coagulation Market, by Disease Indication 12.3.4 Asia Pacific Coagulation Market, by Type 12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer 12.3.5 Asia Pacific Coagulation Market, by Offering 12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis 12.3.5.2 Asia Pacific Coagulation Market, by Treatment 12.3.6 Asia Pacific Coagulation Market, by Technology 12.3.7 Asia Pacific Coagulation Market, by End User 12.3.8 Asia Pacific Coagulation Market by Country 12.3.8.1 China 12.3.8.1.1 Overview 12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.1.3 China Coagulation Market, by Disease Indication 12.3.8.1.4 China Coagulation Market, by Type 12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.1.5 China Coagulation Market, by Offering 12.3.8.1.5.1 China Coagulation Market, by Diagnosis 12.3.8.1.5.2 China Coagulation Market, by Treatment 12.3.8.1.6 China Coagulation Market, by Technology 12.3.8.1.7 China Coagulation Market, by End User 12.3.8.2 Japan 12.3.8.2.1 Overview 12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.2.3 Japan Coagulation Market, by Disease Indication 12.3.8.2.4 Japan Coagulation Market, by Type 12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.2.5 Japan Coagulation Market, by Offering 12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis 12.3.8.2.5.2 Japan Coagulation Market, by Treatment 12.3.8.2.6 Japan Coagulation Market, by Technology 12.3.8.2.7 Japan Coagulation Market, by End User 12.3.8.3 India 12.3.8.3.1 Overview 12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.3.3 India Coagulation Market, by Disease Indication 12.3.8.3.4 India Coagulation Market, by Type 12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.3.5 India Coagulation Market, by Offering 12.3.8.3.5.1 India Coagulation Market, by Diagnosis 12.3.8.3.5.2 India Coagulation Market, by Treatment 12.3.8.3.6 India Coagulation Market, by Technology 12.3.8.3.7 India Coagulation Market, by End User 12.3.8.4 Australia 12.3.8.4.1 Overview 12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.4.3 Australia Coagulation Market, by Disease Indication 12.3.8.4.4 Australia Coagulation Market, by Type 12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.4.5 Australia Coagulation Market, by Offering 12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis 12.3.8.4.5.2 Australia Coagulation Market, by Treatment 12.3.8.4.6 Australia Coagulation Market, by Technology 12.3.8.4.7 Australia Coagulation Market, by End User 12.3.8.5 South Korea 12.3.8.5.1 Overview 12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.5.3 South Korea Coagulation Market, by Disease Indication 12.3.8.5.4 South Korea Coagulation Market, by Type 12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.5.5 South Korea Coagulation Market, by Offering 12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis 12.3.8.5.5.2 South Korea Coagulation Market, by Treatment 12.3.8.5.6 South Korea Coagulation Market, by Technology 12.3.8.5.7 South Korea Coagulation Market, by End User 12.3.8.6 Rest of Asia Pacific 12.3.8.6.1 Overview 12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication 12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type 12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer 12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering 12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis 12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment 12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology 12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User 12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030 12.4.1 Overview 12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.3 Middle East & Africa Coagulation Market, by Disease Indication 12.4.4 Middle East & Africa Coagulation Market, by Type 12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer 12.4.5 Middle East & Africa Coagulation Market, by Offering 12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis 12.4.5.2 Middle East & Africa Coagulation Market, by Treatment 12.4.6 Middle East & Africa Coagulation Market, by Technology 12.4.7 Middle East & Africa Coagulation Market, by End User 12.4.7.1 Middle East & Africa Coagulation Market by Country 12.4.7.2 Saudi Arabia 12.4.7.2.1 Overview 12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication 12.4.7.2.4 Saudi Arabia Coagulation Market, by Type 12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering 12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis 12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment 12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology 12.4.7.2.7 Saudi Arabia Coagulation Market, by End User 12.4.7.3 South Africa 12.4.7.3.1 Overview 12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.3.3 South Africa Coagulation Market, by Disease Indication 12.4.7.3.4 South Africa Coagulation Market, by Type 12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.3.5 South Africa Coagulation Market, by Offering 12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis 12.4.7.3.5.2 South Africa Coagulation Market, by Treatment 12.4.7.3.6 South Africa Coagulation Market, by Technology 12.4.7.3.7 South Africa Coagulation Market, by End User 12.4.7.4 UAE 12.4.7.4.1 Overview 12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.4.3 UAE Coagulation Market, by Disease Indication 12.4.7.4.4 UAE Coagulation Market, by Type 12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.4.5 UAE Coagulation Market, by Offering 12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis 12.4.7.4.5.2 UAE Coagulation Market, by Treatment 12.4.7.4.6 UAE Coagulation Market, by Technology 12.4.7.4.7 UAE Coagulation Market, by End User 12.4.7.5 Rest of Middle East & Africa 12.4.7.5.1 Overview 12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication 12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type 12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer 12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering 12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis 12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment 12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology 12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User 12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030 12.5.1 Overview 12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.3 South & Central America Coagulation Market, by Disease Indication 12.5.4 South & Central America Coagulation Market, by Type 12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer 12.5.5 South & Central America Coagulation Market, by Offering 12.5.5.1 South & Central America Coagulation Market, by Diagnosis 12.5.5.2 South & Central America Coagulation Market, by Treatment 12.5.6 South & Central America Coagulation Market, by Technology 12.5.7 South & Central America Coagulation Market, by End User 12.5.8 South & Central America Coagulation Market by Country 12.5.8.1 Brazil 12.5.8.1.1 Overview 12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.8.1.3 Brazil Coagulation Market, by Disease Indication 12.5.8.1.4 Brazil Coagulation Market, by Type 12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer 12.5.8.1.5 Brazil Coagulation Market, by Offering 12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis 12.5.8.1.5.2 Brazil Coagulation Market, by Treatment 12.5.8.1.6 Brazil Coagulation Market, by Technology 12.5.8.1.7 Brazil Coagulation Market, by End User 12.5.8.2 Argentina 12.5.8.2.1 Overview 12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.8.2.3 Argentina Coagulation Market, by Disease Indication 12.5.8.2.4 Argentina Coagulation Market, by Type 12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer 12.5.8.2.5 Argentina Coagulation Market, by Offering 12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis 12.5.8.2.5.2 Argentina Coagulation Market, by Treatment 12.5.8.2.6 Argentina Coagulation Market, by Technology 12.5.8.2.7 Argentina Coagulation Market, by End User 12.5.8.3 Rest of South & Central America 12.5.8.3.1 Overview 12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) 12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication 12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type 12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer 12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering 12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis 12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment 12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology 12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User 13. Coagulation Market–Industry Landscape 13.1 Overview 13.2 Growth Strategies in the Coagulation Market 13.3 Inorganic Growth Strategies 13.3.1 Overview 13.4 Organic Growth Strategies 13.4.1 Overview 14. Company Profiles 14.1 Siemens Healthineers AG 14.1.1 Key Facts 14.1.2 Business Description 14.1.3 Products and Services 14.1.4 Financial Overview 14.1.5 SWOT Analysis 14.1.6 Key Developments 14.2 Diagnostica Stago, Inc 14.2.1 Key Facts 14.2.2 Business Description 14.2.3 Products and Services 14.2.4 Financial Overview 14.2.5 SWOT Analysis 14.2.6 Key Developments 14.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti. 14.3.1 Key Facts 14.3.2 Business Description 14.3.3 Products and Services 14.3.4 Financial Overview 14.3.5 SWOT Analysis 14.3.6 Key Developments 14.4 Nordic Biomarker AB 14.4.1 Key Facts 14.4.2 Business Description 14.4.3 Products and Services 14.4.4 Financial Overview 14.4.5 SWOT Analysis 14.4.6 Key Developments 14.5 Sysmex Corp 14.5.1 Key Facts 14.5.2 Business Description 14.5.3 Products and Services 14.5.4 Financial Overview 14.5.5 SWOT Analysis 14.5.6 Key Developments 14.6 Helena Laboratories Corporation 14.6.1 Key Facts 14.6.2 Business Description 14.6.3 Products and Services 14.6.4 Financial Overview 14.6.5 SWOT Analysis 14.6.6 Key Developments 14.7 F. Hoffmann-La Roche Ltd 14.7.1 Key Facts 14.7.2 Business Description 14.7.3 Products and Services 14.7.4 Financial Overview 14.7.5 SWOT Analysis 14.7.6 Key Developments 14.8 Genrui Biotech Co., Ltd. 14.8.1 Key Facts 14.8.2 Business Description 14.8.3 Products and Services 14.8.4 Financial Overview 14.8.5 SWOT Analysis 14.8.6 Key Developments 14.9 Transasia Bio-Medicals Ltd 14.9.1 Key Facts 14.9.2 Business Description 14.9.3 Products and Services 14.9.4 Financial Overview 14.9.5 SWOT Analysis 14.9.6 Key Developments 14.10 Horiba Ltd. 14.10.1 Key Facts 14.10.2 Business Description 14.10.3 Products and Services 14.10.4 Financial Overview 14.10.5 SWOT Analysis 14.10.6 Key Developments 15. Appendix 15.1 About Us 15.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
The Insight Partners社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(hemophilia)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|